Search research articles
Contact Us
Filters
Showing results (341-350 of 381) with videos related to
Page
of 39
Sort By:
Neuro-Oncology
|
December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
Antonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
Carcinogenesis
|
November 2, 2015
Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study
Irene Orlow, Anne S Reiner, Nancy E Thomas, et al.
International Journal of Cancer
|
November 11, 2014
Inherited variation at MC1R and ASIP and association with melanoma-specific survival
Nicholas J Taylor, Anne S Reiner, Colin B Begg, et al.
Human Mutation
|
September 8, 2011
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
Jennifer D Brooks, Sharon N Teraoka, Anne S Reiner, et al.
Neuro-Oncology
|
January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)
Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.
Blood
|
December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Christian Grommes, Sarah S Tang, Julia Wolfe, et al.
Radiation Research
|
August 17, 2023
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy
Gordon P Watt, Susan A Smith, Rebecca M Howell, et al.
International Journal of Cancer
|
March 3, 2011
Vitamin D receptor polymorphisms in patients with cutaneous melanoma
Irene Orlow, Pampa Roy, Anne S Reiner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 6, 2019
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists
Carmen Bergom, Catharine M West, Daniel S Higginson, et al.
Journal of the National Cancer Institute
|
May 19, 2017
Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study
Mark E Robson, Anne S Reiner, Jennifer D Brooks, et al.
Page
of 39
Search research articles
Search
Showing results (341-350 of 381) with videos related to
Sort By:
Page
of 39
Neuro-Oncology
|
December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
Antonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
Carcinogenesis
|
November 2, 2015
Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study
Irene Orlow, Anne S Reiner, Nancy E Thomas, et al.
International Journal of Cancer
|
November 11, 2014
Inherited variation at MC1R and ASIP and association with melanoma-specific survival
Nicholas J Taylor, Anne S Reiner, Colin B Begg, et al.
Human Mutation
|
September 8, 2011
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study
Jennifer D Brooks, Sharon N Teraoka, Anne S Reiner, et al.
Neuro-Oncology
|
January 20, 2026
Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)
Lauren R Schaff, Elena Pentsova, Rachna Malani, et al.
Blood
|
December 21, 2018
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
Christian Grommes, Sarah S Tang, Julia Wolfe, et al.
Radiation Research
|
August 17, 2023
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation Therapy
Gordon P Watt, Susan A Smith, Rebecca M Howell, et al.
International Journal of Cancer
|
March 3, 2011
Vitamin D receptor polymorphisms in patients with cutaneous melanoma
Irene Orlow, Pampa Roy, Anne S Reiner, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 6, 2019
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists
Carmen Bergom, Catharine M West, Daniel S Higginson, et al.
Journal of the National Cancer Institute
|
May 19, 2017
Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study
Mark E Robson, Anne S Reiner, Jennifer D Brooks, et al.
Page
of 39